The Offering: Northwest Biotherapeutics

Earlier this morning, Northwest Biotherapeutics announced that they have entered definitive agreements in a 3.5 million share direct offering with healthcare focused institutional investors. Detailed in the press release, the company looks to gain gross proceeds of $12.6 million. Coupled with this share offering, Northwest Biotherapeutics also announced these shareholders would receive warrants to purchase 1.75 million shares at an exercise price of $4.50/share. Shares of Northwest Biotherapeutics fell on this news as the market opened this morning, trading as low as $3.51/share. Currently, shares are down 19.66% on the day trading at $3.57/share